KR20110021691A - 메트포르민 메탄설폰산염, 그의 제조방법, 그를 포함하는 약학 조성물 및 그를 포함하는 복합제제 - Google Patents
메트포르민 메탄설폰산염, 그의 제조방법, 그를 포함하는 약학 조성물 및 그를 포함하는 복합제제 Download PDFInfo
- Publication number
- KR20110021691A KR20110021691A KR1020100082553A KR20100082553A KR20110021691A KR 20110021691 A KR20110021691 A KR 20110021691A KR 1020100082553 A KR1020100082553 A KR 1020100082553A KR 20100082553 A KR20100082553 A KR 20100082553A KR 20110021691 A KR20110021691 A KR 20110021691A
- Authority
- KR
- South Korea
- Prior art keywords
- metformin
- cancer
- methanesulfonate
- diabetes
- composition
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/24—Y being a hetero atom
- C07C279/26—X and Y being nitrogen atoms, i.e. biguanides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090078549 | 2009-08-25 | ||
KR20090078549 | 2009-08-25 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120059607A Division KR20120065308A (ko) | 2009-08-25 | 2012-06-04 | 메트포르민 메탄설폰산염, 그의 제조방법, 그를 포함하는 약학 조성물 및 그를 포함하는 복합제제 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20110021691A true KR20110021691A (ko) | 2011-03-04 |
Family
ID=43628601
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100082553A KR20110021691A (ko) | 2009-08-25 | 2010-08-25 | 메트포르민 메탄설폰산염, 그의 제조방법, 그를 포함하는 약학 조성물 및 그를 포함하는 복합제제 |
KR1020120059607A KR20120065308A (ko) | 2009-08-25 | 2012-06-04 | 메트포르민 메탄설폰산염, 그의 제조방법, 그를 포함하는 약학 조성물 및 그를 포함하는 복합제제 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120059607A KR20120065308A (ko) | 2009-08-25 | 2012-06-04 | 메트포르민 메탄설폰산염, 그의 제조방법, 그를 포함하는 약학 조성물 및 그를 포함하는 복합제제 |
Country Status (2)
Country | Link |
---|---|
KR (2) | KR20110021691A (fr) |
WO (1) | WO2011025267A2 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014182028A1 (fr) * | 2013-05-07 | 2014-11-13 | 재단법인 통합의료진흥원 | Composition pour le traitement du diabète, contenant un extrait d'yukmijihwangtang |
WO2017063155A1 (fr) * | 2015-10-14 | 2017-04-20 | 吉林海格力斯医药生物科技发展有限公司 | Composé pour le traitement d'une lésion de la moelle osseuse provoquée par la radiothérapie ou la chimiothérapie |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102886045A (zh) | 2005-02-03 | 2013-01-23 | 综合医院公司 | 治疗吉非替尼耐药性癌症的方法 |
AR057854A1 (es) | 2005-11-04 | 2007-12-19 | Wyeth Corp | Combinaciones antineoplasicas con inhibidor de mtor, herceptina y/o hki-272 (e)-n-{4-[3-cloro-4-(2-piridinilmetoxi) anilino]-3-ciano-7-etoxi-6-quinolinil}-4-(dimetilamino)-2-butenamida |
US8022216B2 (en) | 2007-10-17 | 2011-09-20 | Wyeth Llc | Maleate salts of (E)-N-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
EP2915532B1 (fr) | 2008-06-17 | 2016-10-19 | Wyeth LLC | Combinaisons antinéoplasiques contenant du HKI-272 et de la vinorelbine |
JP5681108B2 (ja) | 2008-08-04 | 2015-03-04 | ワイス・エルエルシー | 4−アニリノ−3−シアノキノリンとカペシタビンの抗新生物薬の組合せ |
RU2011139363A (ru) | 2009-04-06 | 2013-05-20 | ВАЙЕТ ЭлЭлСи | Схема лечения рака молочной железы с использованием нератиниба |
CA2780332C (fr) | 2009-11-09 | 2018-01-30 | Wyeth Llc | Spheroides de medicament enrobes et utilisations de ceux-ci pour eliminer ou reduire des affections telles que le vomissement et la diarrhee |
KR101432892B1 (ko) * | 2012-09-17 | 2014-08-21 | 가톨릭대학교 산학협력단 | 메트포민을 이용한 루프스를 포함하는 면역질환의 예방 또는 치료용 조성물 |
CN105330575A (zh) * | 2015-10-14 | 2016-02-17 | 吉林海格力斯医药生物科技发展有限公司 | 一种用于治疗放疗、化疗引起的骨髓损伤的化合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1591114A1 (fr) * | 2004-03-12 | 2005-11-02 | Fournier Laboratories Ireland Limited | Utilisation de la metformine et de l'Orlistat pour le traitement ou la prévention de l'obésité |
KR100774774B1 (ko) * | 2006-07-20 | 2007-11-07 | 일동제약주식회사 | 메트포르민 서방성 제제 및 그 제조방법 |
AR065669A1 (es) * | 2007-03-09 | 2009-06-24 | Indigene Pharmaceuticals Inc | Combinacion de metformina r-(+) lipoato y agentes antihipertensivos para el tratamiento de hiperglucemia diabetica y las complicaciones diabeticas |
-
2010
- 2010-08-25 WO PCT/KR2010/005709 patent/WO2011025267A2/fr active Application Filing
- 2010-08-25 KR KR1020100082553A patent/KR20110021691A/ko not_active Application Discontinuation
-
2012
- 2012-06-04 KR KR1020120059607A patent/KR20120065308A/ko not_active Application Discontinuation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014182028A1 (fr) * | 2013-05-07 | 2014-11-13 | 재단법인 통합의료진흥원 | Composition pour le traitement du diabète, contenant un extrait d'yukmijihwangtang |
US10765647B2 (en) | 2013-05-07 | 2020-09-08 | Comprehensive And Integrative Medicine Institute | Composition for treating diabetes, containing extract of yukmijihwangtang |
WO2017063155A1 (fr) * | 2015-10-14 | 2017-04-20 | 吉林海格力斯医药生物科技发展有限公司 | Composé pour le traitement d'une lésion de la moelle osseuse provoquée par la radiothérapie ou la chimiothérapie |
Also Published As
Publication number | Publication date |
---|---|
WO2011025267A3 (fr) | 2011-07-21 |
WO2011025267A2 (fr) | 2011-03-03 |
KR20120065308A (ko) | 2012-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101190953B1 (ko) | 메트포르민 타우린염, 그의 제조방법, 그를 포함하는 약학 조성물 및 그를 포함하는 복합제제 | |
KR20110021691A (ko) | 메트포르민 메탄설폰산염, 그의 제조방법, 그를 포함하는 약학 조성물 및 그를 포함하는 복합제제 | |
KR101211227B1 (ko) | 메트포르민 아스코르브산염, 그의 제조방법, 그를 포함하는 약학 조성물 및 그를 포함하는 복합제제 | |
KR100926417B1 (ko) | N,n―디메틸 이미도디카르본이미딕 디아미드의 초산염,그의 제조방법 및 그를 포함하는 약제학적 조성물 | |
KR101704683B1 (ko) | 바이구아나이드 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 약학 조성물 | |
KR101190957B1 (ko) | 메트포르민 카페익산염, 그의 제조방법, 그를 포함하는 약학 조성물 및 그를 포함하는 복합제제 | |
KR101275258B1 (ko) | 항암 활성을 나타내는 약제학적 조성물 | |
US20120135952A1 (en) | Butyric acid salt of n,n-dimethyl imidocarbon imidic diamide, method of preparing same, and pharmaceutical compositions and combinations containing same | |
CN102438588B (zh) | 使用联合治疗法治疗疾病的方法 | |
WO2013019058A2 (fr) | Composition pharmaceutique permettant d'inhiber la récidive du cancer ou les métastases | |
EP3937908A1 (fr) | Formulations d'un composé et utilisations associées | |
JP6154878B2 (ja) | アタザナビルを含む錠剤組成物 | |
KR20120031288A (ko) | N,n-디메틸 이미도디카르본이미딕 디아미드의 프로피온산염, 이의 제조방법, 이를 포함하는 약제학적 조성물 및 이를 포함하는 복합제제 | |
EP2814493A2 (fr) | Combinaisons d'inhibiteur d'histone désacétylase et de pazopanib, et leurs utilisations | |
KR101324283B1 (ko) | 바이구아나이드 화합물의 신규 염, 그의 제조방법, 그를 포함하는 약제학적 조성물 | |
KR20110053837A (ko) | N1-(펜에틸)-n2-치환된 바이구아나이드 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 약학 조성물 | |
CN116056711A (zh) | 吡啶-3-甲酸2-[4-[(2,3,4-三甲氧基苯基)甲基]哌嗪-1-基]乙酯的晶体形式和合成方法 | |
KR101104912B1 (ko) | N,n―디메틸 이미도디카르본이미딕 디아미드의 니코틴산염, 그의 제조방법 및 그를 포함하는 약제학적 조성물 | |
KR102656587B1 (ko) | 암의 기원 세포의 사멸용 약학적 조성물 | |
CN113831252A (zh) | 咖啡酸文拉法辛及制备方法和其组合物与用途 | |
JP2024506336A (ja) | 膠芽腫の治療方法 | |
RU2214234C1 (ru) | ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ СВОЙСТВАМИ КАРДИОСЕЛЕКТИВНОГО β1-АДРЕНОБЛОКАТОРА |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
A107 | Divisional application of patent | ||
WITB | Written withdrawal of application |